Literature DB >> 19886671

Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.

Kaleeckal G Harikumar1, John Simms, George Christopoulos, Patrick M Sexton, Laurence J Miller.   

Abstract

The three receptor activity-modifying proteins (RAMPs) have been recognized as being important for the trafficking and function of a subset of family B G protein-coupled receptors, although the structural basis for this has not been well established. In the current work, we use morphological fluorescence techniques, bioluminescence resonance energy transfer, and bimolecular fluorescence complementation to demonstrate that the secretin receptor associates specifically with RAMP3, but not with RAMP1 or RAMP2. We use truncation constructs, peptide competition experiments, and chimeric secretin-GLP1 receptor constructs to establish that this association is structurally specific, dependent on the intramembranous region of the RAMP and TM6 and TM7 of this receptor. There were no observed changes in secretin-stimulated cAMP, intracellular calcium, ERK1/2 phosphorylation, or receptor internalization in receptor-bearing COS or CHO-K1 cells in the presence or absence of exogenous RAMP transfection, although the secretin receptor trafficks normally to the cell surface in these cells in a RAMP-independent manner, resulting in both free and RAMP-associated receptor on the cell surface. RAMP3 association with this receptor was shown to be capable of rescuing a receptor mutant (G241C) that is normally trapped intracellularly in the biosynthetic machinery. Similarly, secretin receptor expression had functional effects on adrenomedullin activity, with increasing secretin receptor expression competing for RAMP3 association with the calcitonin receptor-like receptor to yield a functional adrenomedullin receptor. These data provide important new insights into the structural basis for RAMP3 interaction with a family B G protein-coupled receptor, potentially providing a highly selective target for drug action. This may be representative of similar interactions between other members of this receptor family and RAMP proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19886671      PMCID: PMC2790544          DOI: 10.1021/bi901326k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

1.  Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.

Authors:  Jennifer M Bomberger; Narayanan Parameswaran; Carolyn S Hall; Nambi Aiyar; William S Spielman
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

2.  Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.

Authors:  Kaleeckal G Harikumar; Maria M Morfis; Cayle S Lisenbee; Patrick M Sexton; Laurence J Miller
Journal:  Mol Pharmacol       Date:  2005-10-21       Impact factor: 4.436

3.  Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.

Authors:  Debbie L Hay; George Christopoulos; Arthur Christopoulos; David R Poyner; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2005-02-03       Impact factor: 4.436

Review 4.  Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.

Authors:  C D Ulrich; M Holtmann; L J Miller
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

5.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

6.  Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1.

Authors:  Jennifer M Bomberger; William S Spielman; Carolyn S Hall; Edward J Weinman; Narayanan Parameswaran
Journal:  J Biol Chem       Date:  2005-04-01       Impact factor: 5.157

7.  Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; Keiko Hosohata; Delia I Pinon; Laurence J Miller
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

8.  The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function.

Authors:  Timothy J Fitzsimmons; Xilin Zhao; Stephen A Wank
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

Review 9.  GPCR modulation by RAMPs.

Authors:  Debbie L Hay; David R Poyner; Patrick M Sexton
Journal:  Pharmacol Ther       Date:  2005-08-18       Impact factor: 12.310

10.  Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane.

Authors:  Tristan Bouschet; Stéphane Martin; Jeremy M Henley
Journal:  J Cell Sci       Date:  2005-09-27       Impact factor: 5.285

View more
  24 in total

Review 1.  Regulation of acinar cell function in the pancreas.

Authors:  John A Williams
Journal:  Curr Opin Gastroenterol       Date:  2010-09       Impact factor: 3.287

Review 2.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

3.  Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice.

Authors:  Mahita Kadmiel; Kimberly Fritz-Six; Suruchi Pacharne; Gareth O Richards; Manyu Li; Tim M Skerry; Kathleen M Caron
Journal:  Mol Endocrinol       Date:  2011-05-12

Review 4.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

5.  AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.

Authors:  David Bell; Malcolm Campbell; Matthew Ferguson; Leah Sayers; Liz Donaghy; Anna O'Regan; Victoria Jewhurst; Mark Harbinson
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 6.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.

Authors:  Cordelia J Barrick; Patricia M Lenhart; Ryan T Dackor; Elizabeth Nagle; Kathleen M Caron
Journal:  J Mol Cell Cardiol       Date:  2011-11-04       Impact factor: 5.000

8.  Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor.

Authors:  Quan Chen; Laurence J Miller; Maoqing Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-20       Impact factor: 4.310

9.  G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection.

Authors:  Patricia M Lenhart; Stefan Broselid; Cordelia J Barrick; L M Fredrik Leeb-Lundberg; Kathleen M Caron
Journal:  J Mol Endocrinol       Date:  2013-07-03       Impact factor: 5.098

10.  GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs.

Authors:  Shahar Barbash; Emily Lorenzen; Torbjörn Persson; Thomas Huber; Thomas P Sakmar
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.